A recent study has revealed a surprising connection between a seemingly harmless habit—nose picking—and the potential risk of ...

ProMIS Neurosciences (PMN) announced the initiation of its Phase 1b clinical trial evaluating its lead therapeutic candidate, PMN310, in ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Targeting toxic oligomers without binding to plaque, designed to reduce the risk of ARIA and potentially deliver enhanced ...

Apprehension for Oliviero Toscani, 82 years old, hospitalized since this morning in the emergency room at the Cecina hospital ...